Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Gujarat Inject (Kerala) Ltd.
₹119.90
₹115.00
₹119.90
Data is not available
Markets Today
Historical Performance
As of 08-06-2026 20:05, Gujarat Inject (Kerala) Ltd. share price today is ₹0, with a change of ₹-114.20 (-100.00%) from the previous close of ₹114.2. The stock opened at ₹115.1 and traded between ₹115 and ₹119.9, with a total traded volume of 15586 shares. The company has a market capitalization of ₹175.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹120.25 and ₹19.01, respectively.
Gujarat Inject (Kerala) Ltd. valuation metrics include a P/E ratio of 96.8, and book value of ₹17.20. Profitability indicators show ROE of 15.33%. Gujarat Inject (Kerala) Ltd. has reported revenue of ₹36.32 Cr and net profit of ₹1.81 Cr.
Gujarat Inject (Kerala) Ltd. technical indicators include Day RSI at 72.97, Day MFI at 61.13, Day ADX at 49.3. Additional indicators include Commodity Channel Index (CCI) at 142.1 and Williams %R at -1.82. Momentum indicators show Day MACD at 4.84, Day MACD Signal Line at 4.52, DayATR at 3.93. Rate of Change indicators for Gujarat Inject (Kerala) Ltd. include ROC125 at 310.62 and ROC21 at 7.63.
Exponential moving averages include EMA5 at ₹115.3, EMA10 at ₹112.7, EMA12 at ₹112, EMA20 at ₹109.2, EMA26 at ₹107.1, EMA50 at ₹98.1, EMA100 at ₹81.7, EMA200 at ₹62.2. Simple moving averages include SMA5 at ₹114.4, SMA10 at ₹112.5, SMA20 at ₹108.8, SMA30 at ₹107.3, SMA50 at ₹98.5, SMA100 at ₹77.2, SMA150 at ₹61.3, SMA200 at ₹51.1.
Support levels for Gujarat Inject Kerala are placed at First Support ₹116.63, Second Support ₹113.37, Third Support ₹111.73. Resistance levels are seen at First Resistance ₹121.53, Second Resistance ₹123.17, Third Resistance ₹126.43. Gujarat Inject (Kerala) Ltd. shareholding pattern shows promoter holding at 0%, FII holding at 0%, DII holding at 0%, public holding at 100.01%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 30.70 | 1.63 | 1.58 | 2.42 | 4.24 |
| Operating Expense | 28.43 | 1.71 | 1.54 | 2.32 | 4.15 |
| Operating Profit | 2.27 | -0.09 | 0.03 | 0.10 | 0.09 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Tax | 0.63 | 0.01 | 0.02 | 0.02 | 0.02 |
| Net Profit | 1.64 | 0.04 | 0.07 | 0.07 | 0.07 |
₹119.90
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 100 | 100 | 100 | 100 | 100 | 100 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 34.98 K | 34.98 K | 100.00% |
| Week | 26.89 K | 26.89 K | 100.00% |
| 1 Month | 41.96 K | 41.96 K | 100.00% |
| 6 Month | 51.78 K | 51.78 K | 100.00% |
Positive Breakout First Resistance ( LTP > R1)
Companies with no Debt
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Affordable Stocks with High ROE and Momentum
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Near 52 Week High
Highest Recovery from 52 Week Low
RSI indicating price strength
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹126 | ₹45.25 | ₹550.90 | ₹214.10 | ₹255.10 | ₹41.43 |
| % Change | N/A | 0.00% | 1.05% | -0.90% | -4.99% | 0.00% |
| Revenue TTM (₹ Cr) | - | - | - | - | - | ₹1.27 |
| Net Profit TTM (₹ Cr) | - | - | - | - | - | ₹-0.25 |
| PE TTM | 61.50 | 15.00 | - | 14.40 | 36.40 | -98.10 |
| 1 Year Return | -7.48 | 40.54 | 820.67 | |||
| ROCE | - | - | 3.56 | - | - | - |
Vivimed Labs Ltd.
₹ 6.14
-3.91%
Curis Lifesciences Ltd.
₹ 108.00
-3.57%
Aptus Pharma Ltd.
₹ 234.20
+1.98%
Amanta Healthcare Ltd.
₹ 131.65
-1.38%
Anlon Healthcare Ltd.
₹ 14.15
+1.22%
Medistep Healthcare Ltd.
₹ 19.55
+0.00%
Patel Chem Specialities Ltd.
₹ 87.50
+4.17%
Asston Pharmaceuticals Ltd.
₹ 71.70
+4.43%
Influx Healthtech Ltd.
₹ 233.00
-2.51%
Medicamen Organics Ltd.
₹ 21.00
+0.00%
Amrutanjan Health Care Ltd.
₹ 552.20
+0.03%
Astonea Labs Ltd.
₹ 254.55
-4.98%
Amwill Health Care Ltd.
₹ 39.33
-5.00%
Senores Pharmaceuticals Ltd.
₹ 1001.10
-3.25%
Innova Captab Ltd.
₹ 866.90
-0.07%
Valiant Laboratories Ltd.
₹ 72.40
-1.03%
Shelter Pharma Ltd.
₹ 29.26
-3.21%
Trident Lifeline Ltd.
₹ 243.00
+0.00%
Dipna Pharmachem Ltd.
₹ 7.94
+10.28%
Achyut Healthcare Ltd.
₹ 6.47
-2.41%
Sigachi Industries Ltd.
₹ 21.07
-1.86%
Windlas Biotech Ltd.
₹ 801.10
-1.60%
Vineet Laboratories Ltd.
₹ 33.95
-2.36%
Chandra Bhagat Pharma Ltd.
₹ 43.99
+1.13%
By signing up I certify terms, conditions & privacy policy